BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28516372)

  • 1. Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.
    Fang Y; Yao L; Sun J; Yang R; Chen Y; Tian J; Yang K; Tian L
    J Endocrinol Invest; 2017 Oct; 40(10):1035-1047. PubMed ID: 28516372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of thyroid dysfunction on breast cancer risk: an updated meta-analysis.
    Tran TV; Kitahara CM; Leenhardt L; de Vathaire F; Boutron-Ruault MC; Journy N
    Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Yan Z; Huang H; Li J; Wang J
    Osteoporos Int; 2016 Jan; 27(1):115-25. PubMed ID: 26223189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysis.
    Angelousi AG; Anagnostou VK; Stamatakos MK; Georgiopoulos GA; Kontzoglou KC
    Eur J Endocrinol; 2012 Mar; 166(3):373-81. PubMed ID: 22023791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign thyroid disease is associated with breast cancer: a meta-analysis.
    Hardefeldt PJ; Eslick GD; Edirimanne S
    Breast Cancer Res Treat; 2012 Jun; 133(3):1169-77. PubMed ID: 22434524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis.
    Han M; Wang Y; Jin Y; Zhao X; Cui H; Wang G; Gang X
    Front Endocrinol (Lausanne); 2022; 13():984593. PubMed ID: 36313770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010576. PubMed ID: 26606533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does hypothyroidism increase the risk of breast cancer: evidence from a meta-analysis.
    Wang B; Lu Z; Huang Y; Li R; Lin T
    BMC Cancer; 2020 Aug; 20(1):733. PubMed ID: 32762667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid disorders in patients with myasthenia gravis: A systematic review and meta-analysis.
    Song RH; Yao QM; Wang B; Li Q; Jia X; Zhang JA
    Autoimmun Rev; 2019 Oct; 18(10):102368. PubMed ID: 31404702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis.
    Sheehan PM; Nankervis A; Araujo Júnior E; Da Silva Costa F
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4325-31. PubMed ID: 26383905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of thyroid disease and use of thyroid supplements to breast cancer risk.
    Brinton LA; Hoffman DA; Hoover R; Fraumeni JF
    J Chronic Dis; 1984; 37(12):877-93. PubMed ID: 6526927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyroid hormone imbalance on colorectal cancer carcinogenesis and risk - a systematic review.
    Rostkowska O; Spychalski P; Dobrzycka M; Wilczyński M; Łachiński AJ; Obołończyk Ł; Sworczak K; Kobiela J
    Endokrynol Pol; 2019; 70(2):190-197. PubMed ID: 31039272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis.
    Tran TV; Kitahara CM; de Vathaire F; Boutron-Ruault MC; Journy N
    Endocr Relat Cancer; 2020 Apr; 27(4):245-259. PubMed ID: 32045361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis.
    Darvish L; Ghorbani M; Teshnizi SH; Roozbeh N; Seif F; Bayatiani MR; Knaup C; Amraee A
    Clin Transl Oncol; 2018 Nov; 20(11):1430-1438. PubMed ID: 29761266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid disease in relation to breast cancer.
    Vorherr H
    Klin Wochenschr; 1978 Dec; 56(23):1139-45. PubMed ID: 362055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional thyroid abnormalities in patients with dyshormonal breast disorders and tumors.
    Bazyka DA; Lytvynenko O; Bugaistov S
    Probl Radiac Med Radiobiol; 2013; (18):156-68. PubMed ID: 25191720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.
    Sun J; Yao L; Fang Y; Yang R; Chen Y; Yang K; Tian L
    Int J Endocrinol; 2017; 2017():8130796. PubMed ID: 29081800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.
    Garmendia Madariaga A; Santos Palacios S; Guillén-Grima F; Galofré JC
    J Clin Endocrinol Metab; 2014 Mar; 99(3):923-31. PubMed ID: 24423323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis.
    Shun CB; Donaghue KC; Phelan H; Twigg SM; Craig ME
    Diabet Med; 2014 Feb; 31(2):126-35. PubMed ID: 24103027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between circulating resistin levels and thyroid dysfunction: A systematic review and meta-analysis.
    Zhou L; Song K; Luo W
    Front Endocrinol (Lausanne); 2022; 13():1071922. PubMed ID: 36686437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.